Citi Sticks to Its Buy Rating for Kotak Mahindra Bank Limited (KOTAKBANK.IL)
In a report released yesterday, Kunal Shah CFA from Citi maintained a Buy rating on Kotak Mahindra Bank Limited (KOTAKBANK.IL – Research Report), with a price target of INR2,610.00. The company's shares closed yesterday at INR2,208.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Shah CFA is a 3-star analyst with an average return of 7.6% and a 74.07% success rate. Shah CFA covers the Financial sector, focusing on stocks such as Axis Bank Limited, AU Small Finance Bank Limited, and Bank of Baroda.
Kotak Mahindra Bank Limited has an analyst consensus of Strong Buy, with a price target consensus of INR2,116.88, implying a -4.13% downside from current levels. In a report released on June 16, Morgan Stanley also maintained a Buy rating on the stock with a INR2,650.00 price target.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Upcoming Stock Splits This Week (June 30 to July 4)
These are the upcoming stock splits for the week of June 30 to July 4, based on TipRanks' Stock Splits Calendar. In simple terms, a stock split boosts the number of outstanding shares by issuing more to current shareholders, while keeping the company's overall market value intact. This maneuver lowers the share price, often making the stock more affordable, and therefore more appealing, to everyday investors. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. On the flip side, some companies choose a reverse stock split, merging shares rather than dividing them. This trims the total share count while raising the price per share, again without changing the company's total market worth. Reverse splits are frequently used to meet minimum price requirements on exchanges like the Nasdaq and help avoid delisting. Whether aiming to attract more investors or stay in good standing with exchanges, these corporate moves can send important signals that investors watch closely. Let's take a look at the upcoming stock splits for the week. Ainos (AIMD) – Ainos is a dual-platform AI and biotech company, developing the 'AI Nose' scent digitization platform alongside oral interferon therapeutics for rare and autoimmune diseases. On June 26, Ainos announced a 1‑for‑5 reverse stock split, aiming to lift its share price above Nasdaq's minimum. The split will take effect at market open on June 30. Helius Medical Technologies (HSDT) – Helius Medical Technologies, known for its innovative neuromodulation devices like the PoNS® platform for neurological recovery, announced a 1-for-50 reverse stock split on June 27 to maintain compliance with Nasdaq listing requirements. The split will take effect on June 30, with Helius shares set to trade on a split-adjusted basis starting July 1. APi Group (APG) – APi Group specializes in safety, specialty, and industrial services. On May 21, APG announced a 3‑for‑2 forward stock split, conceived to lower per‑share price, increase retail access, and improve liquidity. The ex‑date is July 1, with adjusted trading beginning that day. Channel Therapeutics (CHRO) – Channel Therapeutics is a pain‑treatment biotech preparing for a merger with Pelthos Therapeutics and a NYSE American uplist. On June 27, the company announced a 10‑for‑1 reverse split to comply with listing standards and support a $50 million private placement. The split is effective before market open July 1, with split‑adjusted trading under 'Pelthos Therapeutics' starting July 2. SciSparc (SPRC) – Tel Aviv–based SciSparc, a clinical-stage developer of central nervous system therapies, announced on June 24 a 1-for-21 reverse share split to raise its share price and maintain compliance with Nasdaq listing standards. The split will take effect at market open on July 3. TipRanks Stock Splits Calendar.
Business Insider
2 hours ago
- Business Insider
New Sell Rating for Nuvoco Vistas Corporation Limited (NUVOCO), the Basic Materials Giant
In a report released on June 27, Sumangal Nevatia from Kotak Mahindra maintained a Sell rating on Nuvoco Vistas Corporation Limited (NUVOCO – Research Report), with a price target of INR350.00. The company's shares closed last Friday at INR356.40. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Nevatia covers the Basic Materials sector, focusing on stocks such as ACC Limited, Ambuja Cements Limited, and Dalmia Bharat Ltd.. According to TipRanks, Nevatia has an average return of 1.3% and a 50.00% success rate on recommended stocks. Nuvoco Vistas Corporation Limited has an analyst consensus of Hold.
Business Insider
2 hours ago
- Business Insider
Kotak Mahindra Keeps Their Sell Rating on Dalmia Bharat Ltd. (DALBHARAT)
Kotak Mahindra analyst Sumangal Nevatia maintained a Sell rating on Dalmia Bharat Ltd. (DALBHARAT – Research Report) on June 27 and set a price target of INR1,650.00. The company's shares closed last Friday at INR2,208.60. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Nevatia is a 2-star analyst with an average return of 1.3% and a 50.00% success rate. Nevatia covers the Basic Materials sector, focusing on stocks such as ACC Limited, Ambuja Cements Limited, and Dalmia Bharat Ltd.. Currently, the analyst consensus on Dalmia Bharat Ltd. is a Hold with an average price target of INR1,900.00.
